The Amputation Cascade: How a 1 cm Ulcer Becomes a Lost Limb
By Ned Swanson, MD, President & Chief Medical Officer, PolarityBio
A 58-year-old man with a 12-year history of type 2 diabetes mentioned, at a routine follow-up that he had a small sore on the bottom of his foot "for a few weeks." He hadn't felt it — he felt almost nothing below his ankles anymore — and it didn't look serious. A centimeter or so. He was sent home with wound care instructions and told to return in two weeks.
He came back six weeks later, when his wife noticed the wound had grown and the skin around it had turned dark. By then, infection had spread into the soft tissue. Imaging showed early osteomyelitis. He was admitted that afternoon. He lost his foot three months later.
Looking back through his chart, there was a note from 14 months earlier: "mild peripheral neuropathy — continue to monitor." He had never been referred to podiatry.
While that was only a hypothetical example, it’s not an uncommon story. A 1-centimeter ulcer on the plantar foot rarely looks like an emergency. It is small, often painless, and easy to file away under “watch and re-check.” But trace almost any major diabetic lower-limb amputation backward, and you arrive at exactly that: a wound that, at some earlier point, looked “simple and manageable.”
The data are unambiguous. Roughly 80–85% of diabetes-related lower-extremity amputations are preceded by a foot ulcer, and about 19% of patients who develop a diabetic foot ulcer (DFU) will go on to a lower-extremity amputation.¹
The ulcer is not an incidental finding on the road to limb loss. It is usually the first visible step.
How Diabetic Foot Ulcers Lead to Amputation
The clearest map of that road is still one of the oldest. In 1990, Pecoraro, Reiber, and Burgess reconstructed the causal pathways behind 80 consecutive lower-limb amputations in patients with diabetes. What they found was not one dominant cause but a chain of compounding ones: in the typical case, a foot ulcer and impaired wound healing were near-universal antecedents, with neuropathy, infection, and ischemia compounding the picture.²
Most amputations sat at the end of a sequence: trauma to an insensate foot, a wound that would not close, infection or ischemia exploiting the open portal, and finally tissue loss.
That the foot was insensate is not a side note. Neuropathy is often why these wounds arrive late: patients cannot feel the trauma that initiates the chain, and often cannot feel the wound deteriorating. The cascade advances in silence, which means clinical vigilance, not patient-reported symptoms, is the primary early-warning mechanism.
The important word in that sequence is…sequence. A cascade unfolds in steps, and that gives us an opportunity to disrupt the steps. The five-step chain: (1) peripheral neuropathy renders the foot insensate; (2) minor, unfelt trauma creates an entry wound; (3) impaired healing stalls closure; (4) infection and/or ischemia exploit the open breach; (5) progressive tissue loss forces amputation. Each link is a potential interruption point.
Why the Open Wound is the Pivot Point
Every day a DFU stays open, infection and ischemia have another opportunity to convert a local problem into a limb-threatening one. This is why chronicity itself, not just wound size, predicts trouble. A useful clinical marker: a wound that has not reduced by at least 50% of its surface area within four weeks is unlikely to heal without escalation,⁶ and that four-week trajectory should inform triage decisions as much as the wound's current appearance.
The downstream stakes are easy to underweight because that Wagner Grade 1 diabetic foot ulcer in front of you looks minor. The numbers are not. Five-year mortality runs roughly 30% or more for adults with a DFU, and greater than 70% following an above-foot amputation, placing diabetic foot disease alongside, or worse than, many common cancers.³
And closure is rarely the end of the story: ulcers recur in about 42% of patients within a year and 65% within three to five years, with a prior contralateral amputation independently raising recurrence risk.⁴
The Window is Real - Diabetic Foot Ulcer Progression
If the cascade were driven by a single irreversible cause, prevention would be a matter of luck. Because it is a sequence, it has interruption points, and the evidence that those points matter is strong. Structured, coordinated foot-care programs have been shown to reduce major amputation rates, which is what you would expect if the deciding factor is how quickly the chain is interrupted rather than any single therapy.⁵
The lesson is not about any one therapy. It is about time and trajectory. The same 1-centimeter ulcer can be the beginning of a healed foot or the beginning of a devastating cascade, and the difference is often how quickly it is recognized as the top of a chain rather than a minor lesion.
So, when you see a small DFU, the useful question may not be “how bad is this wound today?” but “where on the cascade does this patient sit, and how fast are they moving?”
The ulcer itself may be small, but the impact of ‘wait and see’ on a patient’s long-term health may not be.
References
1. Armstrong DG, Tan TW, Boulton AJM, Bus SA. Diabetic foot ulcers: a review. JAMA. 2023;330(1):62–75; McDermott K, Fang M, Boulton AJM, Selvin E, Hicks CW. Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers. Diabetes Care. 2023;46(1):209–221.
2. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care. 1990;13(5):513–521.
3. Armstrong DG, et al. JAMA. 2023;330(1):62–75; McDermott K, et al. Diabetes Care. 2023;46(1):209–221; Armstrong DG, Swerdlow MA, Armstrong AA, Conte MS, Padula WV, Bus SA. Five-year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J Foot Ankle Res. 2020;13(1):16.
4. Armstrong DG, et al. JAMA. 2023;330(1):62–75; McDermott K, et al. Diabetes Care. 2023;46(1):209–221. (Recurrence ~42% at 1 year, ~65% at 3–5 years; contralateral amputation independently increases recurrence.)
5. Weck M, Slesaczeck T, Paetzold H, et al. Structured health care for subjects with diabetic foot ulcers results in a reduction of major amputation rates. Cardiovasc Diabetol. 2013;12:45.
6. Sheehan P, Jones P, Caselli A, Giurini JM, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care. 2003;26(6):1879–1882.